Home › Leukemia › Texas › Dallas

Pag-aaral pangklinika para sa Leukemia sa Dallas, TX

Isang pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3

Texas Oncology-Presbyterian Cancer Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Nagre-recruitPhase 2

University of Texas, Southwestern, Dallas

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3

University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Nagre-recruitPhase 1/2

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1

UT Southwestern - Simmons Cancer Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Leukemia sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.